Uptake of pneumococcal vaccination in older people in northern Israel
The 23-valent pneumococcal vaccine is recommended for people aged 65 years and over, to prevent pneumonia, a leading cause of infectious morbidity in older people. This study assessed pneumococcal vaccination in people aged 65–74 years living in northern Israel who were eligible for the pneumococcal...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2021-12-01
|
Series: | Preventive Medicine Reports |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2211335521002436 |
_version_ | 1818342579756859392 |
---|---|
author | Sophia Eilat-Tsanani Ayelet Vashitz-Giwnewer |
author_facet | Sophia Eilat-Tsanani Ayelet Vashitz-Giwnewer |
author_sort | Sophia Eilat-Tsanani |
collection | DOAJ |
description | The 23-valent pneumococcal vaccine is recommended for people aged 65 years and over, to prevent pneumonia, a leading cause of infectious morbidity in older people. This study assessed pneumococcal vaccination in people aged 65–74 years living in northern Israel who were eligible for the pneumococcal vaccine since introduction free of charge. This retrospective study used the database of Clalit Health Services, the largest health maintenance organization in Israel.We fitted a Cox regression model to assess associations of vaccine uptake with sociodemographic and clinical characteristics, and a Wilcoxon rank-sum test and Chi-square test to assess associations of vaccine uptake with the performance of other health-related activities.The analysis included 20,591 people. People aged 65–70 were more likely to take the vaccine than people aged 71–74 [HR = 1.8; CI: 1.6–1.9]. Jews were more likely to take it than Arabs [HR = 1.1; CI: 1.0–1.2], and men were more likely to take it than women [HR = 1.1; CI: 1.0–1.2]. In women who took the vaccine, the rate of performance of mammography was higher (61.9 % ± 45.3 vs 50.3% ± 44.5, p < 0.0001). A similar trend was found for men and women with respect to occult blood tests (36.3% ± 31.5 vs 31.7% ± 30, p < 0.0001).Frequency of visits to family medicine clinics was negatively associated with vaccination.Uptake of the pneumococcal vaccine was associated with some parameters indicative of self-care but not with the level of exposure to the primary health care staff.After-hours health promotion activities by trained personnel may be an effective way to cope with the gap in performance. |
first_indexed | 2024-12-13T16:16:56Z |
format | Article |
id | doaj.art-c00b5b85ebe143458c9cd5012e67ae9c |
institution | Directory Open Access Journal |
issn | 2211-3355 |
language | English |
last_indexed | 2024-12-13T16:16:56Z |
publishDate | 2021-12-01 |
publisher | Elsevier |
record_format | Article |
series | Preventive Medicine Reports |
spelling | doaj.art-c00b5b85ebe143458c9cd5012e67ae9c2022-12-21T23:38:49ZengElsevierPreventive Medicine Reports2211-33552021-12-0124101553Uptake of pneumococcal vaccination in older people in northern IsraelSophia Eilat-Tsanani0Ayelet Vashitz-Giwnewer1The Department of Family Medicine, Clalit Health Services, Northern Region, POB 685, Nof Hagalil 17106 Israel; Azrieli Faculty of Medicine, Bar Ilan University, Safed, Israel; Corresponding author at: Afula region office, Emek Medical Center, 101 Rabin av., Afula, Israel.The Department of Family Medicine, Clalit Health Services, Northern Region, POB 685, Nof Hagalil 17106 IsraelThe 23-valent pneumococcal vaccine is recommended for people aged 65 years and over, to prevent pneumonia, a leading cause of infectious morbidity in older people. This study assessed pneumococcal vaccination in people aged 65–74 years living in northern Israel who were eligible for the pneumococcal vaccine since introduction free of charge. This retrospective study used the database of Clalit Health Services, the largest health maintenance organization in Israel.We fitted a Cox regression model to assess associations of vaccine uptake with sociodemographic and clinical characteristics, and a Wilcoxon rank-sum test and Chi-square test to assess associations of vaccine uptake with the performance of other health-related activities.The analysis included 20,591 people. People aged 65–70 were more likely to take the vaccine than people aged 71–74 [HR = 1.8; CI: 1.6–1.9]. Jews were more likely to take it than Arabs [HR = 1.1; CI: 1.0–1.2], and men were more likely to take it than women [HR = 1.1; CI: 1.0–1.2]. In women who took the vaccine, the rate of performance of mammography was higher (61.9 % ± 45.3 vs 50.3% ± 44.5, p < 0.0001). A similar trend was found for men and women with respect to occult blood tests (36.3% ± 31.5 vs 31.7% ± 30, p < 0.0001).Frequency of visits to family medicine clinics was negatively associated with vaccination.Uptake of the pneumococcal vaccine was associated with some parameters indicative of self-care but not with the level of exposure to the primary health care staff.After-hours health promotion activities by trained personnel may be an effective way to cope with the gap in performance.http://www.sciencedirect.com/science/article/pii/S2211335521002436Pneumococcal vaccineOlder adultsClinic visitsEarly detection of cancerInfluenza vaccine |
spellingShingle | Sophia Eilat-Tsanani Ayelet Vashitz-Giwnewer Uptake of pneumococcal vaccination in older people in northern Israel Preventive Medicine Reports Pneumococcal vaccine Older adults Clinic visits Early detection of cancer Influenza vaccine |
title | Uptake of pneumococcal vaccination in older people in northern Israel |
title_full | Uptake of pneumococcal vaccination in older people in northern Israel |
title_fullStr | Uptake of pneumococcal vaccination in older people in northern Israel |
title_full_unstemmed | Uptake of pneumococcal vaccination in older people in northern Israel |
title_short | Uptake of pneumococcal vaccination in older people in northern Israel |
title_sort | uptake of pneumococcal vaccination in older people in northern israel |
topic | Pneumococcal vaccine Older adults Clinic visits Early detection of cancer Influenza vaccine |
url | http://www.sciencedirect.com/science/article/pii/S2211335521002436 |
work_keys_str_mv | AT sophiaeilattsanani uptakeofpneumococcalvaccinationinolderpeopleinnorthernisrael AT ayeletvashitzgiwnewer uptakeofpneumococcalvaccinationinolderpeopleinnorthernisrael |